PD-1 predicts CD4 loss rate in chronic HIV-1 infection better than HIV RNA and CD38 but not in cryopreserved samples

Current HIV Research

Volumn 6, Issue 1, 2008, Pages 49-58

  Holm, Malin ^a   Pettersen, Frank Olav ^a   Kvale, Dag ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

CD38; Cryopreservation; HIV; PD 1; Prognosis; Progression; T cells

Indexed keywords

ANTIRETROVIRUS AGENT; CD38 ANTIGEN; CELL PROTEIN; PROGRAMMED CELL DEATH 1; UNCLASSIFIED DRUG; VIRUS RNA; APOPTOSIS REGULATORY PROTEIN; BIOLOGICAL MARKER; CD28 ANTIGEN; LEUKOCYTE ANTIGEN; PDCD1 PROTEIN, HUMAN;

ADULT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MATURATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CRYOPRESERVATION; DISEASE COURSE; EXPLORATORY RESEARCH; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LOGISTIC REGRESSION ANALYSIS; MALE; MULTIPLE REGRESSION; PREVALENCE; PROTEIN BLOOD LEVEL; REVIEW; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD; ARTICLE; BLOOD; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDY; DRUG EFFECT; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; VIROLOGY;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIGENS, CD; ANTIGENS, CD28; APOPTOSIS REGULATORY PROTEINS; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CROSS-SECTIONAL STUDIES; CRYOPRESERVATION; DISEASE PROGRESSION; FEMALE; HIV; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RNA, VIRAL;

EID: 40449126764     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016208783571955     Document Type: Review

References (27)

1. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by die quantity of virus in plasma. Science 1996; 272: 1167-1170.
2. Mellors JW, Munoz A, Giorgi JV, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997; 126: 946-954.
3. Rodriguez B, Sethi AK, Cheruvu VK, et al. Predictive value of plasma HIV RNA level on rate of CD4 T cell decline in untreated HIV infection. JAMA 2006; 296: 1498-1506.
4. Hammer SM, Saag MS, Schechter M, et al. Treatment for adult HIV infection: recommendations of the International AIDS Society-USA panel. JAMA 2006; 296: 827-843.
5. Mellors JW, Margolick JB, Phair JP, et al. Prognostic value of HIV-1 RNA, CD4 cell count, and CD4 cell count slope for progression to AIDS and death in untreated HIV-1 infection. JAMA 2007; 297: 2349-2350.
6. Douek DC, Picker LJ, Koup RA. T cell dynamics in HIV-1 infection. Annu Rev Immunol 2003; 21: 265-204.
7. Hazenberg MD, Otto SA, van Benthem BH, et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 2003; 17: 1881-1888.
8. Giorgi JV, Lyles RH, Matud JL, et al. Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection. J Acquir Immune Defic Syndr 2002; 29: 346-355.
9. Savarino A, Bottarel F, Malavasi F, Dianzini U. Role of CD38 in HIV-1 infection: an epiphenomenon of T cell activation or an active player in vitus/host interactions? AIDS 2000; 14: 1079-1089.
10. Barber DL, Wherry EJ, Masopust D, et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006; 439: 682-687.
11. Day CI, Kaufmann DE, Kiepiela P, et al. PD-1 expression on HIV-specific T cells is associated with T cell exhaustion and disease progression. Nature 2006; 443: 282-283.
12. Trautmann L, Janbazian L, Chomont N, et al. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med 2006; 12: 1198-1202.
13. Petrovas C, Casazza JP, Brenchley JM, et al. PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. J Exp Med 2006; 203: 2281-2292.
14. Zhang JY, Zhang Z, Wang X, et al. PD-1 upregulation is correlated with HIV-specific tnemory CD8+ T cell exhaustion in typical progressors, but not in long-term nonprogressors. Blood 2007; 109: 4671-4678.
15. Reimann KA, Chernoff M, Wilkening CL, Nickerson CE, Landay AL. Preservation of lymphocyte immunophenotype and proliferative responses in cryopreserved peripheral blood mononuclear cells from human immunodeficiency virus type 1-infected donors: Implications for multicenter clinical trials. The ACTG Immunology Advanced Technology Laboratories. Clin Diagn Lab Immunol 2000; 7: 352-359.
16. Kran A-MB, Sørensen B, Nyhus. J, et al. HLA- and dose-dependent immunogenicity of a peptide-based HIV-1 immunotherapy candidate (Vace-4x). AIDS 2004; 18: 1875-1883.
17. Kvale D, Kran A-MB, Sommerfelt MA, et al. Divergent in vitro and in vivo correlates of HIV-specific T cell responses during onset HIV viraemia. AIDS 2005; 19: 563-567.
18. Kvale D, Ormaasen V, Kran A-MB, et al. Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment. AIDS 2006; 20: 813-820.
19. Appay V, Dunbar PR, Callan M, et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002; 8:379-385.
20. Hunt PW, Deeks SG, Bangsberg DR, et al. The independent effect of drug resistance on T cell activation in HIV infection. AIDS 2006; 20: 691-699.
21. Velu V, Kannanganat S, Ibegbu C, et al. Elevated expression levels of inhibitory receptor Programmed death 1 on simian immunodefiency virus-specific CD8 T cells during chronic infection but not after vaccination. J Virol 2007; 81: 5819-5828.
22. Rosignoli G, Cranage A, Burton C, et al. Expression of PD-L1, a marker of disease status, is not reduced by HAART in aviraemic patients. AIDS 2007; 21: 1379-1381.
23. Dybul M, Connors M, Fauci AS. The immunology of human immunodeficiency virus infection. In: Mandell GL, Bennett JE, Dolin R Eds, Principles and practice of infectious diseases. Philadelphia, Elsevier Churchill Livingstone. 2005; pp 1527-1546.
24. Deeks SG, Kitchen CM, Liu L, et al. Immune activation set point during early HIV infection predicts subsequent CD4+ T cell changes independent of viral load. Blood 2004; 104: 943-947.
25. Migueles SA, Laborico AC, Shupert WL, et al. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol 2002; 3: 1061-1067.
26. Zhang D, Shankar P, Xu Z, et al. Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic. Blood 2003; 101: 226-235.
27. Perfetto SP, Malone JD, Hawkes C, et al. CD38 expression on cryo-preserved CD8+ T cells predicts HIV disease progression. Cytometry 1998; 33: 133-137.